-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652.P1.111 652. Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 11, 2021: 5:30 PM-7:30 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Nisha Joseph, MD1*, Kathryn T. Maples, PharmD2*, Kevin Hall1*, Vikas A Gupta, MD, PhD3*, Larry H. Boise, PhD3, Leonard T. Heffner, MD4*, Madhav V Dhodapkar, MD5, Craig C. Hofmeister, MD, MPH4, Jonathan L. Kaufman, MD6, Sagar Lonial, MD, FACP5 and Ajay K. Nooka1

1Winship Cancer Institute, Emory University, Atlanta, GA
2Winship Cancer Institute, Emory Healthcare, Atlanta, GA
3Emory University, Atlanta, GA
4Winship Cancer Institute of Emory University, Atlanta, GA
5Emory University School of Medicine, Atlanta, GA
6Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

Alissa Visram1*, S. Vincent Rajkumar, MD2*, Prashant Kapoor, MD2, Angela Dispenzieri, MD2*, Martha Q. Lacy, MD3, Morie A. Gertz, M.D.2, Francis K. Buadi, MB, CHB4*, Suzanne R. Hayman, M.D.2, David Dingli, M.D., Ph.D.2, Taxiarchis Kourelis, M.D.2, Wilson I Gonsalves, MD2, Rahma M Warsame, MD2, Eli Muchtar, MD2, Nelson Leung, MD2, Robert A. Kyle, MD2 and Shaji K Kumar, MD5

1Division of Hematology, Mayo Clinic, Rochester
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic Rochester, Rochester, MN
4Mayo Clinic Rochester, Division of Hematology, Rochester, MN
5Mayo Clinic, Rochester, MN

Aðalbjörg Ýr Sigurbergsdóttir, BSc1*, Sæmundur Rögnvaldsson, MD1*, Sigrun Thorsteinsdottir, MD, PhD2,3, Ingigerdur Solveig Sverrisdottir, MD, BSc1*, Gudrun Asta Sigurdardottir2*, Brynjar Vidarsson, MD4, Pall Torfi Onundarson, MD4, Bjarni Agnar Agnarsson, MD4*, Margret Sigurdardottir, MD4*, Ingunn Thorsteinsdottir, MD, PhD4*, Isleifur Olafsson, MD, PhD4*, Asdis Rosa Thordardottir2*, Gauti Kjartan Gislason, MSc2*, Andri Olafsson2*, Petros Kampanis, PhD5*, Malin Hultcrantz, MD PhD6, Brian G.M. Durie, MD7, Stephen Harding, PhD8, Ola Landgren, MD9, Thorvardur Jon Love, MD, PhD2* and Sigurdur Y Kristinsson, MD, PhD2,10

1Faculty of Medicine, University of Iceland, Reykjavík, Iceland
2Faculty of Medicine, University of Iceland, Reykjavik, Iceland
3Department of Hematology, Rigshospitalet, Copenhagen, Denmark
4Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
5Binding Site Group Ltd., Birmingham, United Kingdom
6Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
8The Binding Site Inc., Birmingham, United Kingdom
9Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
10Landspítali - The University Hospital of Iceland, Reykjavik, Iceland

Nadine Abdallah, MD1*, David L Murray, MD, PhD2*, Angela Dispenzieri, MD3, Prashant Kapoor, MD1, Morie A. Gertz, M.D.1, Martha Q. Lacy, MD4, Suzanne R. Hayman, M.D.1, Francis K. Buadi, MB, CHB5*, Wilson I Gonsalves, MD1, Eli Muchtar, MD1, Nelson Leung, MD4, David Dingli, M.D., Ph.D.1, Taxiarchis Kourelis, M.D.1, Rahma M Warsame, MD1, Moritz Binder, MD, MPH1*, Robert A. Kyle, MD1, S. Vincent Rajkumar, MD1* and Shaji K Kumar, MD3

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic Rochester, Rochester, MN
5Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Arghya Ray, PhD1, Clifton C. Mo, MD2, Ting DU, PhD1*, Arturo Olguin3*, Janice Chen, PhD4*, Christopher L Brooks, PhD5, Tariq I. Mughal, MD, FRCP5,6*, Paul G. Richardson, MD7, Dharminder Chauhan, PhD8* and Kenneth C. Anderson, MD9

1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA
3Stemline Therapeutics Inc., New York, NY
4Stemline Therapeutics, New York, NY
5Stemline Therapeutics Inc, New York, NY
6Tufts University School of Medicine, Boston, MA
7Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics,, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Hannah P. Cutshall1,2*, Kevin D. Arnold1* and Elizabeth E. Brown, PhD, MPH1,3

1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
2School of Medicine, University of Alabama at Birmingham, Birmingham, AL
3O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL

Sheila K Pierson, MSc1*, Adam Bagg, MD2, Daisy Alapat, MD3, Megan S. Lim, MD, PhD4, Mary Jo Lechowicz, MD5, Gordan Srkalovic, MD, PhD6, Thomas S. Uldrick, MD, MS7, Frits van Rhee, MD PhD8 and David C Fajgenbaum, MD, MBA, MSc9

1Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
2Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
3Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
5Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
6Sparrow Herbert-Herman Cancer Center, Lansing, MI
7Fred Hutchinson Cancer Research Center, Seattle, WA
8Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
9Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Sheila K Pierson, MSc1*, Karan Kanhai, MD, PhD2*, Adam Bagg, MD3, Daisy Alapat, MD4, Megan S. Lim, MD, PhD5, Mary Jo Lechowicz, MD6, Gordan Srkalovic, MD, PhD7, Thomas S. Uldrick, MD, MS8, Frits van Rhee, MD PhD9 and David C Fajgenbaum, MD, MBA, MSc10

1Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
2EUSA Pharma, Hemel Hempstead, United Kingdom
3Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
4Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
5Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
6Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
7Sparrow Herbert-Herman Cancer Center, Lansing, MI
8Fred Hutchinson Cancer Research Center, Seattle, WA
9Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
10Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Theodora Alese1*, Benjamin G Barwick, PhD2, Vikas A. Gupta, MD, PhD3, Nisha Joseph, MD1*, Craig C. Hofmeister, MD, MPH4, Mala Shanmugam, PhD5, Jonathan L. Kaufman, MD6, Madhav V Dhodapkar, MD7, Sagar Lonial, MD, FACP7, Ajay K. Nooka1 and Lawrence H. Boise, PhD8

1Winship Cancer Institute, Emory University, Atlanta, GA
2Winship Cancer Institute / Hematology and Medical Oncology, Emory University, Atlanta, GA
3Winship Cancer Institute/ Hematology and Medical Oncology, Emory University, Atlanta, GA
4Winship Cancer Institute / Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
5Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA
6Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
7Emory University School of Medicine, Atlanta, GA
8Emory University, Atlanta, GA

Anwar Khan1*, Nagehan Pakasticali, MD2, Omar Fathalla2*, Taiga Nishihori, MD3 and Mohammad O Hussaini, MD4*

1Florida State University, Tallahassee, FL
2University of South Florida, Tampa, FL
3H. Lee Moffitt Cancer Center, Tampa, FL
4Department of Hematopathology and Lab Medicine, Moffitt Cancer Center, Tampa, FL

Meera Mohan, MD1, Sneha Nagavally, MS2*, Binod Dhakal, MBBS1, Saurabh Chhabra, MD, MS3, Anita D'Souza, MD4* and Parameswaran Hari5

1Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Medical college of Wisconsin, Milwaukee, WI
3Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Malignant Hematology and BMT, Froedtert and Medical College of Wisconsin Cancer Center, Wauwatosa, WI
5Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Meera Mohan, MD1, Zimu Gong, MD2*, Samantha Kendrick, PhD3*, Sharmilan Thanendrarajan, MD4, Carolina Schinke, MD4, Daisy Alapat5*, Guido Tricot, MD, PhD4, Fenghuang Zhan, MD. PhD6, Frits van Rhee, MD PhD4, Jeffery R. Sawyer7*, Erming Tian, PhD, MBA8 and Maurizio Zangari, MD, FACP4

1Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Baylor Scott & White Charles A. Sammons Cancer Center, Houston, TX
3Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR
4Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
5UAMS, Little Rock, AR
6Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer InstituteMyeloma Center, Division of Hematology and Oncology/Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
7Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
8Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR

Wei Yee Chan, MBBS, MRCP1*, Lara Howells, MBChB, MRCP2*, William Wilson3*, Emilie Sanchez, MD4*, Louise Ainley, BMBCh, MA(Oxon), MRCP2*, Selina J Chavda, MBBS, BSc, MRCP, FRCPATH2*, Emma Dowling5*, Nuno Correia5*, Catherine SY Lecat, MBBS2*, Annabel McMillan, MD2*, Brendan Wisniowski, MD2*, Shameem Mahmood, MD2*, Xenofon Papanikolaou, MD2*, Lydia Lee, MD, PhD2*, Jonathan Sive, MD2*, Charalampia Kyriakou, MD, PhD6, Ashutosh D. Wechalekar7*, Rakesh Popat, MBBS, FRCPath, PhD8*, Neil K Rabin, MD, PhD2*, Eleni Nastouli, MD4*, Kwee Yong, MD, PhD9* and Ke Xu, MD, MRCP, FRCPath2

1Department of Haematology, University College London Hospitals NHS Foundation Trust, Wembley, United Kingdom
2Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
3Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom
4Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
5Department of Haematology, HCA Healthcare UK at University College London Hospitals, London, United Kingdom
6University College London Hospital, UCLH Centre for Waldenström and Related Conditions, London, United Kingdom
7University College London Hospitals NHS Foundation Trust, London, United Kingdom
8University College London Hospitals, NHS Foundation Trust, London, United Kingdom
9Department of Haematology, Univer, London, United Kingdom

Fnu Amisha, MD1, Manojna Konda, MD2*, Paras Malik, MD3*, Tyler Fugere, MD1*, Arya Mariam Roy, MD4* and Akash Mukherjee, MD5

1Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
2Department of Haematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
3Department of Internal Medicine, Albert Einstein College of Medicine- Jacobi Medical center, Bronx, NY
4Department of Haematology and Oncology, Roswell park comprehensive cancer center, Amherst, NY
5Department of Haematology/Oncology, Division of Stem cell transplantation and Cellular Therapy, University of Arkansas for Medical Sciences, Little Rock, AR

Sagar Rakshit, MD, Radhika Bansal, MBBS*, Prashant Kapoor, MD, Angela Dispenzieri, MD*, Morie A. Gertz, M.D., Martha Q. Lacy, MD, Suzanne R. Hayman, M.D., Francis K. Buadi, MB, CHB*, Yi L. Hwa, NP, Amie Fonder, PA-C, MS*, Miriam A. Hobbs, APRN, CNP, DNP*, Wilson I Gonsalves, MD, Eli Muchtar, MD*, David Dingli, M.D., Ph.D., Taxiarchis Kourelis, M.D., Rahma M Warsame, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD*, Shaji K Kumar, MD and Nelson Leung, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Karthik Ramasamy1, Herve Avet-Loiseau2, Cecilie Hveding Blimark3*, Michel Delforge4, Francesca Gay5*, Salomon Manier, MD, PhD6, Joaquin Martinez-Lopez7*, Maria-Victoria Mateos8, Mohamad Mohty, MD, PhD9, Niels W.C.J. van de Donk10 and Katja Weisel11*

1Oxford University Hospitals NHS Foundation Trust, Radcliffe Department of Medicine, Oxford University, Oxford, United Kingdom
2University Institute of Cancer Toulouse and University Hospital of Toulouse, Toulouse, France
3Sahlgrenska University Hospital, Gothenburg, Sweden
4University Hospital Leuven, Leuven, Belgium
5University of Turin, Turin, Italy
6University of Lille, Lille, France
7Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
8University Hospital of Salamanca / Salamanca Biomedical Research Institute, Salamanca, Spain
9Hospital Saint-Antoine and Sorbonne University, Paris, France
10Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
11University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Saurabh Zanwar, MD, MBBS1, Matthew Ho, MBBCh, BAO, PhD2*, Prashant Kapoor, MD3, Angela Dispenzieri, MD4, Morie A. Gertz, M.D.3, Martha Q. Lacy, MD5, Francis K. Buadi, MB, CHB6*, Suzanne R. Hayman, M.D.3, David Dingli, M.D., Ph.D.3, Taxiarchis Kourelis, M.D.3, Amie Fonder, PA-C, MS3*, Yi L. Hwa, NP3, Miriam A. Hobbs, APRN, CNP, DNP3*, Wilson I Gonsalves, MD7, Rahma M Warsame, MD3, Eli Muchtar, MD8, Nelson Leung, MD5, Robert A. Kyle, MD3, S. Vincent Rajkumar, MD9* and Shaji K Kumar, MD3

1Division of Hematology, Mayo Clinic, Rochester
2Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Division of Hematology, Mayo Clinic Rochester, Rochester, MN
6Mayo Clinic Rochester, Division of Hematology, Rochester, MN
7Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
8Division of Hematology, Mayo Clinic Rochester, Saint Paul, MN
9Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Nizar J. Bahlis, MD1, Jonathan L. Kaufman, MD2, Rachid Baz, MD3*, Hang Quach, FRACP, FRCPA4, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res5*, Annette J. Vangsted, MD6*, Torben Plesner, MD7, Philippe Moreau, MD, PhD8*, Simon D. Gibbs9*, Eva Medvedova, MD10*, Orlando F. Bueno, MD, PhD11, Yan Luo, MD PhD11*, Christine Mantis, PhD11*, Deeksha Vishwamitra, PhD11*, Jeremy A. Ross, PhD12* and Simon J Harrison, MD13

1Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
2Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
3Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4St. Vincent’s Hospital, Melbourne, VIC, Australia
5Department of Haematology, St George Hospital, Sydney, Australia
6Department of Hematology, Rigshospitalet, Copenhagen, Denmark
7Department of Hematology, Vejle Hospital, Vejle, Denmark
8University Hospital Hôtel-Dieu, Nantes, Nantes, France
9The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Easter Health Clinical School, Melbourne, VIC, Australia
10Oregon Health & Science University, Portland, OR
11AbbVie, Inc., North Chicago, IL
12AbbVie Inc., North Chicago, IL
13Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Nizar J. Bahlis, MD1, Shambavi Richard2*, Darrell J. White, MD3, Sebastian Grosicki, MD, PhD4, Christine Chen, MHPE, MD, FRCPC5*, Sosana Delimpasi, MD6*, Heather J. Sutherland, MD, PhD, FRCPC7, Zvenyslava Maslyak, MD8*, Michael Sebag, MD, PhD9, Maria Gavriatopoulou, MD10*, Suzanne Lentzsch, MD, PhD11*, Ajai Chari, MD12*, Maryana Simonova, MD13*, Ivan Spicka, MD, Prof, PhD14*, Iryna Kriachok15*, Meletios A. Dimopoulos, MD16, Halyna Pylypenko, MD17*, Holger W Auner, MD, PhD18, Xavier Leleu, MD19, Ganna Usenko, MD20*, Roman Hajek, MD, PhD21, Reuben Benjamin, MD22, Tuphan Kanti Dolai, MBBS, MD, DNB, DM23*, Dinesh Kumar Sinha, MD24*, Christopher P. Venner, MD, FRCPC25, Mamta Garg, MD, FRCP, FRCPath26*, Don Stevens, MD27, Hang Quach, FRACP, FRCPA28, Sundar Jagannath, MD29*, Philippe Moreau, MD, PhD30*, Moshe Levy, MD31*, Ashraf Z. Badros, MD32, Larry D. Anderson Jr., MD, PhD33*, Thierry Facon, MD34*, Maria-Victoria Mateos35, Michele Cavo, MD, PhD36*, Andrew DeCastro, PhD37*, Yi Chai, PhD38*, Dane R. Van Domelen, PhD37*, Moran Mishal, MD38*, Ohad S. Bentur, MD MHA37*, Jatin Shah, MD38, Sharon Shacham, PhD, MBA37*, Michael G. Kauffman, MD, PhD37 and Paul G. Richardson, MD39

1Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
2Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
4Silesian Medical University, Katowice, Poland
5Princess Margaret Cancer Center, Toronto, Canada
6Hematology/Lymphomas and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
7Division of Hematology, Vancouver General Hospital, Vancouver, BC, Canada
8State Institution "Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine", Lviv, Ukraine
9Royal Victoria Hospital, Montreal, QC, Canada
10Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens,, Athens, Greece
11Medical Oncology, Columbia University Medical Center, New York, NY
12Mount Sinai, New York, NY
13Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
14Charles University and General Hospital, Prague, Czech Republic
15National Cancer Institute, Kiev, Ukraine
16Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
17Department of Hematology, Cherkassy Regional Oncology Center, Cherkassy, Ukraine
18Imperial College London, London, United Kingdom
19Department of Hematology, CHU Poitiers – Hôpital la Milétrie, Poitiers, France
20City Hematology Center, City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine
21Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
22Department of Haematology, Kings College Hospital NHS Foundation Trust, London, CA, United Kingdom
23Haematology, Nil Ratan Sircar Medical College and Hospital, Kolkata, India
24State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India
25Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
26Leicester Royal Infirmary, Leicester, United Kingdom
27Norton Healthcare, Norton Cancer Institute, Louisville, KY
28University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
29Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
30University Hospital Hotel-Dieu, Nantes, France
31Baylor University Medical Center, Dallas, TX
32School of Medicine, University of Maryland Baltimore, Baltimore, MD
33UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
34CHU Lille Service des Maladies du Sang F-59000, Lille, France
35Hospital Clinico Universitario de Salamanca, Salamanca, Spain
36IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
37Karyopharm Therapeutics Inc., Newton, MA
38Karyopharm Therapeutics, Newton, MA
39Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA

Yuxin Liu, MD1, Bohm Kywe, MD2*, Lake Crawford3*, Federico Lora4*, Noffar Bar, MD1, Sabrina L. Browning, MD1, Elan Gorshein, DO, JD, MPH5*, Terri L. Parker, MD1 and Natalia Neparidze, MD3

1Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
2Department of Internal Medicine, Norwalk Hospital, Norwalk, CT
3Yale University School of Medicine, New Haven, CT
4Cancer Research Opportunities for Youth (CROY) Program, Yale Cancer Center, New Haven, CT
5Smilow Cancer Hospital Care Center- Guilford, Yale University School of Medicine and Yale Cancer Center, Guilford, CT

Efstathios Kastritis1*, Maria Gavriatopoulou, MD1*, Maria Roussou, MD1*, Evangelos Eleutherakis-Papaiakovou, MD, MSc, PhD1*, Magdalini Migkou, MD, PhD1*, Nikolaos Kanellias, MD1*, Despina Fotiou, MD, PhD1*, Foteini Theodorakakou, MD1*, Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD1*, Panagiotis Malandrakis, MD1*, Vasiliki Spiliopoulou, MD1*, Stavroula Giannouli, MD, PhD2*, Evangelos Terpos, MD, PhD1 and Meletios A. Dimopoulos, MD1

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Second Department of Internal Medicine, Hematology Unit, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Hsin-An Hou, MD, PhD1*, Chao-Hsiun Tang, BA, PhD2*, Choo Hua Goh3*, Sarah Siggins, PhD4*, Shih-Pei Shen2*, Hong Qiu, MD, PhD5*, Wen-Chien Chou, MD, PhD6 and Yanfang Liu, MD, MPH3*

1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2School of Health Care Administration, Taipei Medical University, Taipei, Taiwan
3Global Epidemiology, Janssen Research & Development, Singapore, Singapore
4Janssen Medical Affairs, Macquarie Park, Australia
5Janssen Research & Development, Titusville
6Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Louise Redder, MD1*, Sören Möller2*, Anna Thit Johnsen3*, Mary Jarden4*, Christen lykkegaard Andersen5*, Henrik Frederiksen1,6,7*, Henrik Gregersen, MD, PhD8*, Anja Klostergaard9*, Morten Saaby Steffensen10*, Per Troellund Pedersen11*, Maja Hinge12*, Mikael Frederiksen13*, Carsten Helleberg, MD14*, Niels Abildgaard, MD15,16,17 and Lene Kongsgaard Nielsen18,19*

1Department of Hematology, Odense University Hospital, Odense, Denmark
2OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark and Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, DNK
3Department of Psychology, University of Southern Denmark, Odense, Denmark
4The University Hospitals Centre For Health Research, Rigshospitalet, Copenhagen, DNK
5Department of Haematology, Zealand University Hospital, Roskilde, DNK
6Department of Clinical Research, University of Southern Denmark, Odense, Denmark
7Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
8Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
97Department of Haematology, Aarhus University Hospital, Denmark, AArhus, Denmark
10Department of Haematology, Regional Hospital West Jutland, Denmark, Holstebro, DNK
11Department of Haematology, South West Jutland Hospital, Denmark, Esbjerg, Denmark
12Department of Haematology, Vejle Hospital, Denmark, Vejle, DNK
13Department of Hematology, Sygehus Soenderjylland, Aabenraa, Denmark
14Department of Hematology, Herlev Hospital, Herlev, Denmark
15Center for Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
16Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
17Department of Clinical research, University of Southern Denmark, Odense, Denmark
18Quality of Life Research Center, Department of Haematology, Odense University Hospital, Denmark, Odense, DNK
1913 Research Unit for Multimorbidity, Department of Internal Medicine and Cardiology, Viborg Regional Hospital, Denmark, Viborg, Denmark

Iuliana Vaxman, MD, BA1,2,3*, Jithma P. Abeykoon, MD4, Angela Dispenzieri, MD5, Shaji K Kumar, MD5, Francis K. Buadi, MB, CHB2*, Martha Q. Lacy, MD6, David Dingli, M.D., Ph.D.4, Yi Lisa Hwa, CNP, DNP4*, Amie Fonder, PA-C, MS4*, Miriam A. Hobbs, APRN, CNP, DNP4*, Craig B. Reeder, MD7, Taimur Sher, MD8, Suzanne R. Hayman, M.D.4, Taxiarchis Kourelis, M.D.4, Rahma M Warsame, MD4, Eli Muchtar, MD9, Nelson Leung, MD6, Wilson I Gonsalves, MD10, Mustaqeem A. Siddiqui, M.D., M.B.A.4, Robert A. Kyle, MD4, S. Vincent Rajkumar, MD11*, Kirsten McCullough5*, Prashant Kapoor, MD4 and Morie A. Gertz, M.D.4

1Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2Mayo Clinic Rochester, Division of Hematology, Rochester, MN
3Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
4Division of Hematology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Rochester, MN
6Division of Hematology, Mayo Clinic Rochester, Rochester, MN
7Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
8Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
9Division of Hematology, Mayo Clinic Rochester, Saint Paul, MN
10Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
11Division of Hematology, Mayo Clinic, Rochester

Motiur Rahman1*, Christopher Kim, PhD, MPH2, Jazmine Mateus, MPH3* and Alissa Keegan, MD, PhD2

1Amgen, Thousand Oaks, CA
2Amgen Inc, Thousand Oaks, CA
3DOCS, Philadelphia, PA

Angelo Belotti, MD1*, Rossella Ribolla, MD1*, Alberta Villanacci2*, Marco Chiarini, MSc3*, Viviana Giustini, MSc3*, Giulia Vittoria Facchetti4*, Claudia Crippa, MD1*, Valeria Cancelli, MD1*, Samantha Ferrari1*, Annalisa Peli, MD1*, Chiara Bottelli, MD1*, Chiara Cattaneo, MD5*, Chiara Saeli6*, Aldo M. Roccaro, MD, PhD7, Luigi Grazioli, MD8*, Giuseppe Rossi, MD9 and Alessandra Tucci, MD10*

1Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
2Radiology, ASST Spedali Civili di Brescia, Brescia, Italy
3Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
4Hematology, ASST Spedali Civili di Brescia, 25123, Italy
5Hematology, ASST Spedali Civili di Brescia, Brescia, BS, Italy
6Department of Radiology, Spedali Civili di Brescia, Brescia, Italy
7Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy
8Department of Radiology, ASST- Spedali Civili di Brescia, brescia, Italy
9Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
10Hematology, ASST Spedali Civili, Brescia, Italy

Tahani Atieh, DO1, Shebli Atrash, MD2, Meera Mohan, MD, MS3*, Leyla Shune, MD1, Zahra Mahmoudjafari, PhD4*, Julie Quick5*, Justin Riffel5*, Joseph P. McGuirk, DO6, Ghulam Rehman Mohyuddin, MD7, Al-Ola Abdallah, MD8, Nausheen Ahmed, MD4*, Wei Cui5* and Anne Wishna5*

1University of Kansas Cancer Center, Westwood, KS
2Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, University of Arkansas for Medical Sciences, Charlotte, NC
3Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
4Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
5University of Kansas Medical Center, Kansas City, KS
6Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
7University of Utah, Salt Lake City, UT
8Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Alina Varabyeva, PharmD1*, Jens Hillengass2, Wenyan Ji, MA3*, Han Yu, PhD4*, McKenna Butler, PharmD5* and Eugene Przespolewski, PharmD6*

1Roswell Park Comprehensive Cancer Center, BUFFALO, NY
2Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY
5NYU Langone Hospital- Long Island, Mineola, NY
6Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Malin Hultcrantz, MD PhD1, Jennifer Orozco, PharmD2*, Tim J Peterson, PharmD2*, Andriy Derkach, PhD3*, Hani Hassoun, MD1, Neha Korde, MD1, Sydney X. Lu, MD, PhD1, Sham Mailankody, MBBS 1, Dhwani Patel, MD1*, Urvi A Shah, MD1, Carlyn Tan, MD1,4, Kylee H Maclachlan, MD, PhD, BSc, FRACP, FRCPA1, David J. Chung, MD, PhD5, Heather J Landau, MD6, Gunjan L Shah, MD7*, Oscar B Lahoud, MD7, Michael Scordo, MD8, Ola Landgren, MD9, Sergio Giralt, MD10* and Alexander Lesokhin, MD4

1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pharmacy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
7Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
9Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
10Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH